Last year, Synergy CHC Corp generated 29.73M USD for its biggest-performing segment, Nutraceuticals. The United States made the largest contribution, accounting for 27.32M USD last year. For the latest quarter, Synergy CHC Corp reported the revenue of 4.82M USD for the period ending 2026-03-31, which came from the top-performing segment, Nutraceuticals. United States contributed the highest revenue, at 5.22M USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Nutraceuticals

Beverages

Consumer Goods

Others

Cosmeceuticals

Over the Counter (OTC)

FY2025

FY2024

FY2023

FY2020

FY2019

Nutraceuticals

29.73M(97.86%)

33.39M(95.86%)

42.75M(99.94%)

31.90M(79.31%)

28.15M(95.89%)

Beverages

631.33K(2.08%)

1.43M(4.09%)

--(--)

Consumer Goods

17.99K(0.06%)

16.91K(0.05%)

24.58K(0.06%)

1.20M(2.99%)

706.69K(2.41%)

Others

-174.00(--)

--(--)

Cosmeceuticals

--(--)

7.10M(17.65%)

438.56K(1.49%)

Over the Counter (OTC)

--(--)

22.31K(0.06%)

62.36K(0.21%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Canada

Mexico

Other

Foreign countries

FY2025

FY2024

FY2023

FY2020

FY2019

United States

27.32M(89.92%)

30.83M(79.39%)

40.62M(94.96%)

30.68M(76.28%)

27.30M(92.97%)

Canada

2.42M(7.96%)

3.93M(10.11%)

--(--)

Mexico

623.66K(2.05%)

3.64K(0.01%)

--(--)

Other

20.72K(0.07%)

73.05K(0.19%)

--(--)

Foreign countries

--(--)

4.00M(10.31%)

2.16M(5.04%)

9.54M(23.72%)

2.06M(7.03%)